PDB Short entry for 3SR4 HEADER TRANSFERASE/TRANSFERASE INHIBITOR 06-JUL-11 3SR4 TITLE CRYSTAL STRUCTURE OF HUMAN DOT1L IN COMPLEX WITH A SELECTIVE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN OF HDOT1L (UNP RESIDUES 1-351); COMPND 5 SYNONYM: DOT1-LIKE PROTEIN, HISTONE H3-K79 METHYLTRANSFERASE, H3-K79- COMPND 6 HMTASE, LYSINE N-METHYLTRANSFERASE 4; COMPND 7 EC: 2.1.1.43; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DOT1L, KIAA1814, KMT4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-KG KEYWDS HDOT1, HISTONE LYSINE METHYLTRANSFERASE, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.DIAO,P.CHEN,Y.YAO,B.V.V.PRASAD,Y.SONG REVDAT 3 13-SEP-23 3SR4 1 REMARK REVDAT 2 16-NOV-11 3SR4 1 JRNL REVDAT 1 05-OCT-11 3SR4 0 JRNL AUTH Y.YAO,P.CHEN,J.DIAO,G.CHENG,L.DENG,J.L.ANGLIN,B.V.PRASAD, JRNL AUTH 2 Y.SONG JRNL TITL SELECTIVE INHIBITORS OF HISTONE METHYLTRANSFERASE DOT1L: JRNL TITL 2 DESIGN, SYNTHESIS, AND CRYSTALLOGRAPHIC STUDIES. JRNL REF J.AM.CHEM.SOC. V. 133 16746 2011 JRNL REFN ISSN 0002-7863 JRNL PMID 21936531 JRNL DOI 10.1021/JA206312B REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.3 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1042822.880 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 23019 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1154 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.54 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1101 REMARK 3 BIN R VALUE (WORKING SET) : 0.3440 REMARK 3 BIN FREE R VALUE : 0.3920 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 50 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.055 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2671 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 91 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 63.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 64.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.77000 REMARK 3 B22 (A**2) : -8.77000 REMARK 3 B33 (A**2) : 17.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.30 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.33 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.810 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.620 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.820 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.260 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.500 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 60.78 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 6 : TT8_PAR.TXT REMARK 3 PARAMETER FILE 7 : ACT_PAR.TXT REMARK 3 PARAMETER FILE 8 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 6 : TT8_TOP.TXT REMARK 3 TOPOLOGY FILE 7 : ACT_TOP.TXT REMARK 3 TOPOLOGY FILE 8 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3SR4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUL-11. REMARK 100 THE DEPOSITION ID IS D_1000066548. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JUN-11 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 5.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS HTC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23040 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : 12.90 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.14000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.86300 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1NW3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 70.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 20 MM TRIS, PH 8.0, REMARK 280 200 MM NACL, 1 MM EDTA, 10% GLYCEROL, 3 MM INHIBITOR, 3 MM TCEP. REMARK 280 RESERVOIR SOLUTION: 0.1 M HAC, PH 5.3, 1.25-1.7 M (NH4)2SO4. , REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 33.92600 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 16.96300 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 25.44450 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 8.48150 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 42.40750 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 GLU A 3 REMARK 465 LYS A 4 REMARK 465 LYS A 333 REMARK 465 LEU A 334 REMARK 465 ARG A 335 REMARK 465 GLU A 336 REMARK 465 GLU A 337 REMARK 465 GLN A 338 REMARK 465 GLU A 339 REMARK 465 ALA A 340 REMARK 465 ALA A 341 REMARK 465 ARG A 342 REMARK 465 ARG A 343 REMARK 465 ARG A 344 REMARK 465 GLN A 345 REMARK 465 GLN A 346 REMARK 465 ARG A 347 REMARK 465 GLU A 348 REMARK 465 SER A 349 REMARK 465 LYS A 350 REMARK 465 SER A 351 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 57 103.90 -42.43 REMARK 500 VAL A 59 71.73 -117.15 REMARK 500 ILE A 61 -2.86 56.72 REMARK 500 ASP A 62 50.06 -62.62 REMARK 500 ASN A 127 45.00 -80.46 REMARK 500 SER A 302 94.02 -168.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TT8 A 417 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 700 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NW3 RELATED DB: PDB REMARK 900 RELATED ID: 3QOW RELATED DB: PDB REMARK 900 RELATED ID: 3QOX RELATED DB: PDB DBREF 3SR4 A 1 351 UNP Q8TEK3 DOT1L_HUMAN 1 351 SEQRES 1 A 351 MET GLY GLU LYS LEU GLU LEU ARG LEU LYS SER PRO VAL SEQRES 2 A 351 GLY ALA GLU PRO ALA VAL TYR PRO TRP PRO LEU PRO VAL SEQRES 3 A 351 TYR ASP LYS HIS HIS ASP ALA ALA HIS GLU ILE ILE GLU SEQRES 4 A 351 THR ILE ARG TRP VAL CYS GLU GLU ILE PRO ASP LEU LYS SEQRES 5 A 351 LEU ALA MET GLU ASN TYR VAL LEU ILE ASP TYR ASP THR SEQRES 6 A 351 LYS SER PHE GLU SER MET GLN ARG LEU CYS ASP LYS TYR SEQRES 7 A 351 ASN ARG ALA ILE ASP SER ILE HIS GLN LEU TRP LYS GLY SEQRES 8 A 351 THR THR GLN PRO MET LYS LEU ASN THR ARG PRO SER THR SEQRES 9 A 351 GLY LEU LEU ARG HIS ILE LEU GLN GLN VAL TYR ASN HIS SEQRES 10 A 351 SER VAL THR ASP PRO GLU LYS LEU ASN ASN TYR GLU PRO SEQRES 11 A 351 PHE SER PRO GLU VAL TYR GLY GLU THR SER PHE ASP LEU SEQRES 12 A 351 VAL ALA GLN MET ILE ASP GLU ILE LYS MET THR ASP ASP SEQRES 13 A 351 ASP LEU PHE VAL ASP LEU GLY SER GLY VAL GLY GLN VAL SEQRES 14 A 351 VAL LEU GLN VAL ALA ALA ALA THR ASN CYS LYS HIS HIS SEQRES 15 A 351 TYR GLY VAL GLU LYS ALA ASP ILE PRO ALA LYS TYR ALA SEQRES 16 A 351 GLU THR MET ASP ARG GLU PHE ARG LYS TRP MET LYS TRP SEQRES 17 A 351 TYR GLY LYS LYS HIS ALA GLU TYR THR LEU GLU ARG GLY SEQRES 18 A 351 ASP PHE LEU SER GLU GLU TRP ARG GLU ARG ILE ALA ASN SEQRES 19 A 351 THR SER VAL ILE PHE VAL ASN ASN PHE ALA PHE GLY PRO SEQRES 20 A 351 GLU VAL ASP HIS GLN LEU LYS GLU ARG PHE ALA ASN MET SEQRES 21 A 351 LYS GLU GLY GLY ARG ILE VAL SER SER LYS PRO PHE ALA SEQRES 22 A 351 PRO LEU ASN PHE ARG ILE ASN SER ARG ASN LEU SER ASP SEQRES 23 A 351 ILE GLY THR ILE MET ARG VAL VAL GLU LEU SER PRO LEU SEQRES 24 A 351 LYS GLY SER VAL SER TRP THR GLY LYS PRO VAL SER TYR SEQRES 25 A 351 TYR LEU HIS THR ILE ASP ARG THR ILE LEU GLU ASN TYR SEQRES 26 A 351 PHE SER SER LEU LYS ASN PRO LYS LEU ARG GLU GLU GLN SEQRES 27 A 351 GLU ALA ALA ARG ARG ARG GLN GLN ARG GLU SER LYS SER HET TT8 A 417 27 HET GOL A 500 6 HET ACT A 600 4 HET SO4 A 700 5 HETNAM TT8 (2S)-2-AZANYL-4-[[(2S,3S,4R,5R)-5-[6-(METHYLAMINO) HETNAM 2 TT8 PURIN-9-YL]-3,4-BIS(OXIDANYL)OXOLAN-2- HETNAM 3 TT8 YL]METHYLSULFANYL]BUTANOIC ACID HETNAM GOL GLYCEROL HETNAM ACT ACETATE ION HETNAM SO4 SULFATE ION HETSYN TT8 S-(N6-METHYLADENOSYL)-L-HOMOCYSTEINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 TT8 C15 H22 N6 O5 S FORMUL 3 GOL C3 H8 O3 FORMUL 4 ACT C2 H3 O2 1- FORMUL 5 SO4 O4 S 2- FORMUL 6 HOH *91(H2 O) HELIX 1 1 ALA A 33 ILE A 48 1 16 HELIX 2 2 ILE A 48 ASN A 57 1 10 HELIX 3 3 SER A 67 TRP A 89 1 23 HELIX 4 4 SER A 103 VAL A 119 1 17 HELIX 5 5 ASP A 121 ASN A 127 5 7 HELIX 6 6 SER A 140 ILE A 151 1 12 HELIX 7 7 GLY A 167 THR A 177 1 11 HELIX 8 8 ALA A 188 GLY A 210 1 23 HELIX 9 9 SER A 225 ASN A 234 1 10 HELIX 10 10 GLY A 246 ALA A 258 1 13 HELIX 11 11 ASP A 286 THR A 289 5 4 HELIX 12 12 ARG A 319 ASN A 331 1 13 SHEET 1 A 2 GLU A 6 LEU A 9 0 SHEET 2 A 2 ALA A 18 PRO A 21 -1 O TYR A 20 N LEU A 7 SHEET 1 B 2 VAL A 26 ASP A 28 0 SHEET 2 B 2 HIS A 31 ASP A 32 -1 O HIS A 31 N TYR A 27 SHEET 1 C 7 TYR A 216 ARG A 220 0 SHEET 2 C 7 HIS A 181 GLU A 186 1 N GLY A 184 O GLU A 219 SHEET 3 C 7 LEU A 158 LEU A 162 1 N PHE A 159 O TYR A 183 SHEET 4 C 7 VAL A 237 VAL A 240 1 O PHE A 239 N VAL A 160 SHEET 5 C 7 ARG A 265 SER A 268 1 O ARG A 265 N ILE A 238 SHEET 6 C 7 TYR A 313 ILE A 317 -1 O HIS A 315 N ILE A 266 SHEET 7 C 7 MET A 291 GLU A 295 -1 N VAL A 294 O LEU A 314 CISPEP 1 TRP A 22 PRO A 23 0 0.07 CISPEP 2 ASN A 331 PRO A 332 0 -0.23 SITE 1 AC1 20 PRO A 133 TYR A 136 GLY A 137 GLU A 138 SITE 2 AC1 20 THR A 139 ASP A 161 GLY A 163 SER A 164 SITE 3 AC1 20 GLN A 168 VAL A 169 GLU A 186 LYS A 187 SITE 4 AC1 20 GLY A 221 ASP A 222 PHE A 223 PHE A 239 SITE 5 AC1 20 PHE A 245 HOH A 365 HOH A 391 HOH A 419 SITE 1 AC2 4 HIS A 31 ASP A 32 ASN A 116 HOH A 434 SITE 1 AC3 4 VAL A 160 TYR A 183 ARG A 231 THR A 235 SITE 1 AC4 4 ARG A 203 LYS A 207 HIS A 213 HOH A 381 CRYST1 152.753 152.753 50.889 90.00 90.00 120.00 P 65 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006547 0.003780 0.000000 0.00000 SCALE2 0.000000 0.007559 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019651 0.00000